GS 4071,
GS 4104,
GS-4071,
GS-4104,
GS4071,
GS4104,
Oseltamivir,
Tamiflu,
Oseltamivir phosphate,
204255-11-8,
Tamiflu,
Oseltamivir (phosphate),
Oseltamir Phosphate,
UNII-4A3O49NGEZ,
GS4104,
4A3O49NGEZ,
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate,
CHEBI:7799,
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1),
Ro 64-0796/002,
GS 4104,
Osteltamivir phosphate,
(3R-(3alpha,4beta,5alpha))-Ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1),
GS-4104,
Oseltamivir phosphate, 98%,
(3R-(3alpha,4beta,5alpha)-Ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1),
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, phosphate (1:1),
C16H28N2O4.H3PO4,
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha)-, phosphate (1:1),
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate, phosphate (1:1),
ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; phosphoric acid,
Ro-64-0796,
Oseltamivir Phosphate [USAN],
SR-05000001499,
C16H28N2O4.H3O4P,
Ebilfumin (TN),
Oseltamivir phosphate [USAN:USP],
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate;phosphoric acid,
Tamiflu (TN),
AC1L2U9Q,
SCHEMBL8730,
oseltamivir-phosphate-Tamiflu,
MLS006011559,
CHEMBL1200340,
DTXSID0044230,
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate phosphate,
PGZUMBJQJWIWGJ-ONAKXNSWSA-N,
BCPP000138,
Oseltamivir phosphate (JAN/USAN),
ACT03369,
ABP000749,
MFCD08059548,
s2597,
AKOS015896056,
BCP9001033,
CCG-230250,
CS-0871,
KS-1184,
MCULE-3939535663,
RL02533,
Oseltamivir phosphate, >=98% (HPLC),
Ro 64-0796,
AC-25911,
BC216470,
HY-17016,
SMR004703323,
AB0011433,
LS-173828,
Ro-640796002,
ST24048849,
GS-4104/002,
Ro-64-0796-002,
Ro-64-0796/002,
C08093,
D00900,
J10429,
W-5362,
255O118,
SR-05000001960,
I06-1861,
J-013302,
J-523838,
SR-05000001499-2,
SR-05000001960-1,
Z1550675456,
Oseltamivir phosphate, United States Pharmacopeia (USP) Reference Standard,
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate phosphate,
Oseltamivir phosphate (impurity B free), European Pharmacopoeia (EP) Reference Standard,
Oseltamivir Phosphate, Pharmaceutical Secondary Standard; Certified Reference Material,
(3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid ethyl ester phosphate,
(3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid ethyl ester phosphoric acid salt,
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, phosphate,
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; phosphoric acid,
phosphoric acid ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate,
oseltamivir,
Oseltamivirphosphate,
cc-563,
Oseltamivir phosphate (Tamiflu),
CID78000,
GS 4071,
ACN-040773,
CS-O-02016,
C16-H28-N2-O4.H3-O4-P,
B1803,
A11653,
(3R,5S)-Ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate phosphate,
(3R,5S)-ethyl4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate,